LA Eye, LLC has patented the Titanium Scleral (Macular) Buckle for application in various stages of pathologic myopia. MSD is designed to address the anatomic root cause of the problem in pathologic myopia helping to reshape the contours of the posterior sclera to a more natural form and reduce the axial length so to treat or prevent blinding myopic maculopathy. An additional gain appears to be a large reduction of the refractive error.
The Titanium Scleral (Macular) Buckle was presented on July 13, 2022 in New York City.
